Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 11.60
+0.30 (2.65%)
At close: Mar 4, 2026
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 15.93 million as of March 4, 2026. Its market cap has decreased by -30.08% in one year.
Market Cap
15.93M
Enterprise Value
13.67M
Revenue
15.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.60
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 15.93M, a decrease of -85.99%. That is a compound annual growth rate of -22.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 15.93M | 16.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 57.56M |
| AcouSort AB | 50.16M |
| 2cureX AB | 40.29M |
| Modus Therapeutics Holding AB | 36.12M |
| Nanologica AB | 34.46M |
| Guard Therapeutics International AB | 33.28M |
| ExpreS2ion Biotech Holding AB | 24.18M |
| Aptahem AB | 18.16M |